• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡复发的预防——药物治疗与手术治疗。医生的观点。

Prevention of ulcer recurrence--medical vs surgical treatment. The physician's view.

作者信息

Walan A, Ström M

出版信息

Scand J Gastroenterol Suppl. 1985;110:83-8. doi: 10.3109/00365528509095836.

DOI:10.3109/00365528509095836
PMID:2862699
Abstract

What factors should be considered in the choice between medical and surgical treatment of peptic ulcer disease? We would suggest the factors included in Table I. It is our opinion that we have concentrated too much on the recurrence rate, that is on how many of the patients who have a recurrence and not so much on the severity of recurrences in terms of symptoms, duration and influence on ability to work. It is also our firm belief that with regard to costs too much attention has been paid to one small part of the total cost, namely the cost for drugs. The strategy in the choice of the treatment for patients with a peptic ulcer depends on many factors as shown in Table II. At our department, the pharmacological part of the treatment of the first episode of an active duodenal ulcer as well as the first recurrences will usually consist of cimetidine 800 mg as a single nocturnal dose or in divided doses, for 4-6 weeks. Antacids are often given for relief of pain. The treatment will be continued for another 2 weeks if the patient is not symptomless after 4 weeks. The patient is then instructed to make further contact in the event of new symptoms suggesting a recurrence. Personally, we usually perform another endoscopy at that time as a guidance for the decision whether to give maintenance treatment or not. If we find an ulcer or signs of duodenitis, we give another 4-6 weeks course of cimetidine.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在消化性溃疡疾病的药物治疗和手术治疗之间进行选择时应考虑哪些因素?我们建议参考表I中所列因素。我们认为,我们过于关注复发率,即有多少患者复发,而对于复发的严重程度,如症状、持续时间以及对工作能力的影响关注不足。我们还坚信,在成本方面,人们过多地关注了总成本中的一小部分,即药物成本。消化性溃疡患者治疗方法的选择策略取决于许多因素,如表II所示。在我们科室,对于活动性十二指肠溃疡首次发作以及首次复发的药物治疗,通常会采用西咪替丁800毫克,夜间单次服用或分剂量服用,持续4至6周。常给予抗酸剂以缓解疼痛。如果4周后患者仍有症状,则治疗将再持续2周。然后告知患者如果出现提示复发的新症状需进一步联系。我们个人通常会在那时再次进行内镜检查,以指导决定是否给予维持治疗。如果发现溃疡或十二指肠炎迹象,我们会再给予4至6周的西咪替丁疗程。(摘要截选至250词)

相似文献

1
Prevention of ulcer recurrence--medical vs surgical treatment. The physician's view.溃疡复发的预防——药物治疗与手术治疗。医生的观点。
Scand J Gastroenterol Suppl. 1985;110:83-8. doi: 10.3109/00365528509095836.
2
Ulcer disease of the upper gastrointestinal tract.上消化道溃疡病
Hosp Pract (Off Ed). 1984 Oct;19(10):177-80, 190, 192 passim.
3
H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.H2受体拮抗剂与十二指肠溃疡复发:疗效分析及关于安全性、成本和患者选择的评论
Am J Gastroenterol. 1987 Dec;82(12):1242-9.
4
Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.用奥美拉唑或持续使用H2受体拮抗剂治疗难治性消化性溃疡:一项对照临床试验。
Gut. 1991 Apr;32(4):435-8. doi: 10.1136/gut.32.4.435.
5
History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.我们有生之年的历史:组胺H2受体拮抗剂时代难治性十二指肠溃疡性质的变化
Dig Liver Dis. 2003 Aug;35(8):529-36. doi: 10.1016/s1590-8658(03)00269-x.
6
Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.确定H2受体拮抗剂治疗的最佳给药方案——一种剂量验证方法。
Aliment Pharmacol Ther. 1989 Feb;3(1):47-57. doi: 10.1111/j.1365-2036.1989.tb00190.x.
7
[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].[组胺H2受体拮抗剂治疗和预防十二指肠溃疡及胃溃疡]
Wien Med Wochenschr. 1983;133(4-5):104-7.
8
[Changes in the surgical directions in the treatment of gastric and duodenal ulcers].[胃十二指肠溃疡治疗中手术方向的变化]
Minerva Chir. 1985;40(1-2):33-44.
9
Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.H2受体拮抗剂用于十二指肠溃疡的维持治疗——一项荟萃分析
Aliment Pharmacol Ther. 1990 Jun;4(3):283-94. doi: 10.1111/j.1365-2036.1990.tb00473.x.
10
Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.组胺2受体拮抗剂在胃十二指肠溃疡出血中的应用
Scand J Gastroenterol Suppl. 1985;110:95-100. doi: 10.3109/00365528509095838.